IRCT20200705048013N1已完成3 期
Evaluation of the effects of Pentoxifylline in improving the condition of patients with Covid-19
Karaj University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 no limit（—）
- 性别
- All
入选标准
- •Clinical signs of fever (above 38.3 °C), dyspnea and cough
- •Definite diagnosis of of Covid-19 based on RT-PCR
排除标准
- •Chronic cardiovascular disease
- •Obesity (with BMI higher than 30 kg/m2)
- •Chronic kidney disease
- •End-stage renal disease with hemodialysis
研究者
相似试验
尚未招募
3 期
Evaluation of the effect of pentoxifylline on the prevention of erythrocyte lysis in cardiac surgery patientsAll patients undergo open heart surgery.IRCT20210420051018N1Semnan University of Medical Sciences15
尚未招募
3 期
Investigation of the effect of pentoxifylline on Covid-19IRCT20170609034406N8Tabriz University of Medical Sciences100
已完成
2 期
The evaluation of the effect of pentoxifylline on diabetic foot ulcersIRCT20180818040823N1Tehran University of Medical Sciences18
尚未招募
2 期
The effect of Pentoxifylline for the treatment of major depression in cardiovascular patientsIRCT20090117001556N132Tehran University of Medical Sciences50
招募中
3 期
The effect of pentoxifylline on diabetic microalbuminuriaAlbuminuria in patients with diabetes Mellitus type II.Diabetes mellitus due to underlying condition with kidney complicationsE08.2IRCT20190107042264N3Ahvaz University of Medical Sciences58